OACC
Oaktree Acquisition Corp. III Life Sciences
Financial Services — Shell Companies
Oaktree Acquisition Corp. III Life Sciences does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It intends to target companies in the biopharmaceutical, medical devices, diagnostics, and specialized healthcare services sectors in North America and Europe. The company was founded in 1995 and is headquartered in Los Angeles, California.
None
$10.78
(0.00%)
Price History
52-Week Range
Sign in to add OACC to a watchlist or set price alerts.
Fundamentals
| Market Cap | $263.04M |
| P/E Ratio (TTM) | 36.90 |
| Forward P/E | - |
| EPS (TTM) | $0.29 |
| Dividend Yield | - |
| Profit Margin | - |
| Revenue Growth | - |
| ROE | - |
| Debt/Equity | - |
| Recommendation | None |
| Analyst Target | - |
| Analysts | - |
| Next Earnings | - |
| Indexes | - |
Technical Indicators
| RSI (14) | 66.7 |
| Beta | - |
| SMA 20 | - |
| SMA 40 | - |
| 52-Week High | $10.74 |
| 52-Week Low | $10.30 |
| 50-Day Avg | $10.66 |
| 200-Day Avg | $10.62 |
| Avg Volume | 11.7K |
| Volume | 7 |
Performance Analysis
NEUTRALOACC presents a mixed picture with both positive and negative indicators.
-
Trading near its 52-week high ($10.74), which may indicate limited upside.
+
RSI at 66.7 shows positive momentum.
+
Price is above both the 50-day and 200-day moving averages — strong uptrend.
~
Wall Street consensus is "none".
Recent News
Loading news...
Last updated: Jul 02, 2026 13:24 UTC
Back to Screener Export Report